Hello, Fool! | Login | Signup | My Fool
Nov 19, 2008 10:35 AM ET | Feedback | Site Changes | Help
The Company provides weight management and fitness products and services.
View All Commentary (NTRI)
Recs
germo (< 20) Submitted: 10/19/07 1:31 PM : Start Price: $27.19 NTRI Score: -13.79
After getting whacked 20% with a missed forecast, they have now seen the full effect of Glaxo's new weight loss drug Alli take some of their business. This was an overreaction to bad news and now that NTRI has seen the effect of Alli, '08 marketing and planning will be better able to address what needs to be done to combat Alli. They should rebound nicely especially after New Year's Resolution time.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.